This study investigates the role of P2X7 in ALS pathogenesis and provides a ‘proof of concept’ for the use of P2X7 antagonism as a strategy to ameliorate the neuroinflammatory component of ALS disease. This evidence concerns the gene P2RX7 and amyotrophic lateral sclerosis.